Patents by Inventor Angela BLAKE-HASKINS

Angela BLAKE-HASKINS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY FORMULATION
    Publication number: 20220175922
    Abstract: The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.
    Type: Application
    Filed: November 5, 2021
    Publication date: June 9, 2022
    Inventors: Angela BLAKE-HASKINS, Tristan MARSHALL, Melissa D. PERKINS, Kristin O'BERRY
  • BLyS antibody formulation
    Patent number: 11179463
    Abstract: The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: November 23, 2021
    Inventors: Angela Blake-Haskins, Tristan Marshall, Melissa D. Perkins, Kristin O'Berry
  • ANTIBODY FORMULATION
    Publication number: 20200222535
    Abstract: The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.
    Type: Application
    Filed: January 7, 2020
    Publication date: July 16, 2020
    Inventors: Angela Blake-Haskins, Tristan Marshall, Melissa D. Perkins, Kristin O'Berry
  • Anti-Blys antibody formulations and methods of treatment using them
    Patent number: 10556009
    Abstract: The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: February 11, 2020
    Assignee: GlaxoSmithKline Intellectual Property Management Limited
    Inventors: Angela Blake-Haskins, Tristan Marshall, Melissa D. Perkins, Kristin O'Berry
  • ANTIBODY FORMULATION
    Publication number: 20180289804
    Abstract: The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.
    Type: Application
    Filed: June 13, 2018
    Publication date: October 11, 2018
    Inventors: Angela BLAKE-HASKINS, Tristan MARSHALL, Melissa D. PERKINS, Kristin O'BERRY
  • ANTIBODY FORMULATION
    Publication number: 20170095555
    Abstract: The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.
    Type: Application
    Filed: May 15, 2015
    Publication date: April 6, 2017
    Inventors: Angela BLAKE-HASKINS, Tristan MARSHALL, Melissa D. PERKINS, Kristen O'BERRY